Our approach to the management of oral thrush in children ≥12 months

Predisposing factors for oral thrush in children ≥12 months include cellular immune deficiency and treatment with antibiotics, inhaled glucocorticoids, chemotherapy, or radiation therapy. Evaluation for cellular immune deficiency may be warranted for children ≥12 months who develop thrush in the absence of a predisposing factor.

HIV: human immunodeficiency virus; IV: intravenous.

* Nystatin solution should be swished and held in the mouth as long as possible before being swallowed.

¶ Lozenges should not be used in children younger than four years.

Δ IV fluconazole may be warranted for immunocompromised children with thrush and oropharyngeal pain that interferes with eating.

◊ Fluconazole-resistant Candida may be suspected in children who are known to be colonized with a resistant species (eg, Candida glabrata, Candida krusei), children who have been receiving azole antifungal prophylaxis, and children cared for in medical centers with a high proportion of resistant species.

§ Refer to drug monograph included within UpToDate for dosing.

Graphic 115622 Version 3.0

خرید پکیج

Our approach to the management of oral thrush in children ≥12 months